Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT
Clinical trial NCT04476199 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04476199
- Sponsor
- Gruppo Italiano Trapianto di Midollo Osseo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2023-02-03
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.